136 related articles for article (PubMed ID: 31194608)
21. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.
Huo D; Ikpatt F; Khramtsov A; Dangou JM; Nanda R; Dignam J; Zhang B; Grushko T; Zhang C; Oluwasola O; Malaka D; Malami S; Odetunde A; Adeoye AO; Iyare F; Falusi A; Perou CM; Olopade OI
J Clin Oncol; 2009 Sep; 27(27):4515-21. PubMed ID: 19704069
[TBL] [Abstract][Full Text] [Related]
22. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran.
Yari K; Payandeh M; Rahimi Z
Tumour Biol; 2016 Jun; 37(6):8145-52. PubMed ID: 26715274
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer in young women in Ibadan, Nigeria.
Ntekim A; Nufu FT; Campbell OB
Afr Health Sci; 2009 Dec; 9(4):242-6. PubMed ID: 21503175
[TBL] [Abstract][Full Text] [Related]
24. Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity.
Guerrero-Preston R; Hadar T; Ostrow KL; Soudry E; Echenique M; Ili-Gangas C; Pérez G; Perez J; Brebi-Mieville P; Deschamps J; Morales L; Bayona M; Sidransky D; Matta J
Oncol Rep; 2014 Aug; 32(2):505-12. PubMed ID: 24927296
[TBL] [Abstract][Full Text] [Related]
25. Body fat distribution and breast cancer risk: findings from the Nigerian breast cancer study.
Ogundiran TO; Huo D; Adenipekun A; Campbell O; Oyesegun R; Akang E; Adebamowo C; Olopade OI
Cancer Causes Control; 2012 Apr; 23(4):565-74. PubMed ID: 22367701
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
27. Design considerations for identifying breast cancer risk factors in a population-based study in Africa.
Brinton LA; Awuah B; Nat Clegg-Lamptey J; Wiafe-Addai B; Ansong D; Nyarko KM; Wiafe S; Yarney J; Biritwum R; Brotzman M; Adjei AA; Adjei E; Aitpillah F; Edusei L; Dedey F; Nyante SJ; Oppong J; Osei-Bonsu E; Titiloye N; Vanderpuye V; Brew Abaidoo E; Arhin B; Boakye I; Frempong M; Ohene Oti N; Okyne V; Figueroa JD
Int J Cancer; 2017 Jun; 140(12):2667-2677. PubMed ID: 28295287
[TBL] [Abstract][Full Text] [Related]
28. Histological Features and Tissue Microarray Taxonomy of Nigerian Breast Cancer Reveal Predominance of the High-Grade Triple-Negative Phenotype.
Titloye NA; Foster A; Omoniyi-Esan GO; Komolafe AO; Daramola AO; Adeoye OA; Adisa AO; Manoharan A; Pathak D; D'Cruz MN; Alizadeh Y; Lewis PD; Shaaban AM
Pathobiology; 2016; 83(1):24-32. PubMed ID: 26730581
[TBL] [Abstract][Full Text] [Related]
29. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study.
White AJ; Chen J; McCullough LE; Xu X; Cho YH; Teitelbaum SL; Neugut AI; Terry MB; Hibshoosh H; Santella RM; Gammon MD
Cancer Causes Control; 2015 Dec; 26(12):1791-802. PubMed ID: 26407953
[TBL] [Abstract][Full Text] [Related]
30. Lead exposure: a contributing cause of the current breast cancer epidemic in Nigerian women.
Alatise OI; Schrauzer GN
Biol Trace Elem Res; 2010 Aug; 136(2):127-39. PubMed ID: 20195925
[TBL] [Abstract][Full Text] [Related]
31. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients.
Van der Auwera I; Bovie C; Svensson C; Trinh XB; Limame R; van Dam P; van Laere SJ; van Marck EA; Dirix LY; Vermeulen PB
BMC Cancer; 2010 Mar; 10():97. PubMed ID: 20226036
[TBL] [Abstract][Full Text] [Related]
32. Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study.
Deroo LA; Bolick SC; Xu Z; Umbach DM; Shore D; Weinberg CR; Sandler DP; Taylor JA
Carcinogenesis; 2014 Feb; 35(2):333-8. PubMed ID: 24130171
[TBL] [Abstract][Full Text] [Related]
33. Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa.
Osafo C; Raji YR; Burke D; Tayo BO; Tiffin N; Moxey-Mims MM; Rasooly RS; Kimmel PL; Ojo A; Adu D; Parekh RS;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2279-87. PubMed ID: 26138261
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.
McCormack VA; Joffe M; van den Berg E; Broeze N; Silva Idos S; Romieu I; Jacobson JS; Neugut AI; Schüz J; Cubasch H
Breast Cancer Res; 2013; 15(5):R84. PubMed ID: 24041225
[TBL] [Abstract][Full Text] [Related]
35. Increased epigenetic age in normal breast tissue from luminal breast cancer patients.
Hofstatter EW; Horvath S; Dalela D; Gupta P; Chagpar AB; Wali VB; Bossuyt V; Storniolo AM; Hatzis C; Patwardhan G; Von Wahlde MK; Butler M; Epstein L; Stavris K; Sturrock T; Au A; Kwei S; Pusztai L
Clin Epigenetics; 2018 Aug; 10(1):112. PubMed ID: 30157950
[TBL] [Abstract][Full Text] [Related]
36. Case-control study of body size and breast cancer risk in Nigerian women.
Ogundiran TO; Huo D; Adenipekun A; Campbell O; Oyesegun R; Akang E; Adebamowo C; Olopade OI
Am J Epidemiol; 2010 Sep; 172(6):682-90. PubMed ID: 20716701
[TBL] [Abstract][Full Text] [Related]
37. Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk.
Brennan K; Garcia-Closas M; Orr N; Fletcher O; Jones M; Ashworth A; Swerdlow A; Thorne H; ; Riboli E; Vineis P; Dorronsoro M; Clavel-Chapelon F; Panico S; Onland-Moret NC; Trichopoulos D; Kaaks R; Khaw KT; Brown R; Flanagan JM
Cancer Res; 2012 May; 72(9):2304-13. PubMed ID: 22374981
[TBL] [Abstract][Full Text] [Related]
38. Metastatic breast cancer in a Nigerian tertiary hospital.
Adisa AO; Arowolo OA; Akinkuolie AA; Titiloye NA; Alatise OI; Lawal OO; Adesunkanmi AR
Afr Health Sci; 2011 Jun; 11(2):279-84. PubMed ID: 21857862
[TBL] [Abstract][Full Text] [Related]
39. The severity, outcome and challenges of breast cancer in Nigeria.
Adesunkanmi AR; Lawal OO; Adelusola KA; Durosimi MA
Breast; 2006 Jun; 15(3):399-409. PubMed ID: 16085418
[TBL] [Abstract][Full Text] [Related]
40. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
